Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT00102622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
ClinicalTrials.gov study NCT04942301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT01358071. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT02146313. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT05496166. IPD Sharing: NO. Countries: 1. Publications: 0.
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04764149. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT04457089. IPD Sharing: NO. Countries: 1. Publications: 0.
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT06855069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
ClinicalTrials.gov study NCT07035067. IPD Sharing: NO. Countries: 1. Publications: 0.
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT06905509. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
ClinicalTrials.gov study NCT04667572. IPD Sharing: NO. Countries: 1. Publications: 0.
BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy
ClinicalTrials.gov study NCT01672671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01469793. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria
ClinicalTrials.gov study NCT04369352. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Platinum Based Chemotherapy Plus Indomethacin
ClinicalTrials.gov study NCT01719926. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy
ClinicalTrials.gov study NCT03826589. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
ClinicalTrials.gov study NCT06157827. IPD Sharing: NO. Countries: 1. Publications: 0.
Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)
ClinicalTrials.gov study NCT05329545. IPD Sharing: NO. Countries: 3. Publications: 0.
Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP
ClinicalTrials.gov study NCT04826198. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
ClinicalTrials.gov study NCT00274885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.